Back

Circulating-tumor DNA from Two Types of Blood Collection Tubes for Monitoring Tumor Burden Validated with Esophageal Squamous Cell Carcinoma Patients

Endo, F.; Iwaya, T.; Sasaki, Y.; Chiba, T.; Yaegashi, M.; Kume, K.; Sato, K.; Arisue, A.; Kawagishi, R.; Matuo, T.; Akiyama, Y.; Sasaki, A.; Suzuki, Y.; Tokino, T.; Masuda, M.; Yamada, T.; Nakagawa, H.; Nishizuka, S. S.

2020-08-14 oncology
10.1101/2020.08.12.20173070 medRxiv
Show abstract

ObjectiveTo evaluate long-term whole blood (WB) storage at room temperature (RT), plasma and peripheral blood mononuclear cell (PBMC) DNA was collected simultaneously using BD Vacutainer(R) CPTTM Mononuclear Cell Preparation Tubes (CPT) and Streck Cell-Free DNA Blood Collection Tubes (BCT(R)). MethodsPlasma DNA was isolated from both types of tubes at various time points at RT. DNA from PBMCs was extracted using CPT from WB stored in BCT. The extracted DNA was used to monitor esophageal cancer treatment. ResultsBCT maintained steady levels of plasma DNA for up to nine days. After transfer of BCT-stored WB to CPT, PBMC-DNA were yielded with suitable quality for up to seven days. ctDNA from esophageal cancer patients carrying TP53 mutations reflected treatment efficacy. ConclusionBCT/CPT combinatory procedure allows storage of blood samples for up to seven days at RT for valid clinical assays using ctDNA.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.